会议材料

ASCO GU 2026 - 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2026
American Society of Clinical Oncology Genitourinary Cancers Symposium 2026
-
美国 · 旧金山

本内容仅供您个人及教育用途。请勿下载或进一步传播。未经版权所有者许可,不得进一步复制或传播

共2条结果
会议壁报
Are long-term remissions possible with hormonal therapy only? Post hoc analysis of EMBARK examining sustained prostate-specific antigen <0.2 ng/mL despite testosterone recovery after treatment suspension
Shore ND, De Giorgi U, Gleave M, Kalac M, Tang Y, Croitoru R, Rosales M, Patel MI, Finelli A, Schiffman Z, Lantz A, Freedland SJ
ASCO GU 2026 - 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2026 | 肿瘤 | 前列腺癌 | 泌尿系统肿瘤
会议壁报
Real-world outcomes associated with enzalutamide vs apalutamide in metastatic castration-sensitive prostate cancer: Analysis of United States oncology electronic health record data
Morgans AK, DerSarkissian M, Bobbili PJ, Chen N, Duh MS, Touya M, Razo JF, Ivanova JI
ASCO GU 2026 - 美国临床肿瘤学会泌尿生殖系统肿瘤研讨会 2026 | 肿瘤 | 前列腺癌 | 泌尿系统肿瘤